Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1124505.RA7WNh24SSCW2cMyXWjt-BMXf4rjAdDhODUCOQ7Nlu6C8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1124505.RA7WNh24SSCW2cMyXWjt-BMXf4rjAdDhODUCOQ7Nlu6C8130_assertion type Assertion NP1124505.RA7WNh24SSCW2cMyXWjt-BMXf4rjAdDhODUCOQ7Nlu6C8130_head.
- NP1124505.RA7WNh24SSCW2cMyXWjt-BMXf4rjAdDhODUCOQ7Nlu6C8130_assertion description "[FHIT loss was observed in 64% of NSCLC patients and was significantly associated with SCC (P=0.003) and poor tumor grade (P=0.043).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1124505.RA7WNh24SSCW2cMyXWjt-BMXf4rjAdDhODUCOQ7Nlu6C8130_provenance.
- NP1124505.RA7WNh24SSCW2cMyXWjt-BMXf4rjAdDhODUCOQ7Nlu6C8130_assertion evidence source_evidence_literature NP1124505.RA7WNh24SSCW2cMyXWjt-BMXf4rjAdDhODUCOQ7Nlu6C8130_provenance.
- NP1124505.RA7WNh24SSCW2cMyXWjt-BMXf4rjAdDhODUCOQ7Nlu6C8130_assertion SIO_000772 24185125 NP1124505.RA7WNh24SSCW2cMyXWjt-BMXf4rjAdDhODUCOQ7Nlu6C8130_provenance.
- NP1124505.RA7WNh24SSCW2cMyXWjt-BMXf4rjAdDhODUCOQ7Nlu6C8130_assertion wasDerivedFrom befree-2016 NP1124505.RA7WNh24SSCW2cMyXWjt-BMXf4rjAdDhODUCOQ7Nlu6C8130_provenance.
- NP1124505.RA7WNh24SSCW2cMyXWjt-BMXf4rjAdDhODUCOQ7Nlu6C8130_assertion wasGeneratedBy ECO_0000203 NP1124505.RA7WNh24SSCW2cMyXWjt-BMXf4rjAdDhODUCOQ7Nlu6C8130_provenance.